Shenzhen Neptunus Interlong Bio-technique Company Limited (HKG:8329)
Hong Kong
· Delayed Price · Currency is HKD 0.150
+0.003 (2.04%)
At close: Mar 10, 2026
HKG:8329 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 993.11 | 1,042 | 1,065 | 986.69 | 838.81 | 1,031 | Upgrade
|
| Revenue Growth (YoY) | -5.76% | -2.17% | 7.92% | 17.63% | -18.67% | -4.58% | Upgrade
|
| Cost of Revenue | 704.37 | 713.66 | 625.62 | 543.01 | 470.67 | 458.93 | Upgrade
|
| Gross Profit | 288.74 | 328.04 | 439.24 | 443.68 | 368.13 | 572.44 | Upgrade
|
| Selling, General & Admin | 250.08 | 256.27 | 343.26 | 337.96 | 318.65 | 485.03 | Upgrade
|
| Other Operating Expenses | 27.43 | 32.74 | 45 | 17.45 | 11.3 | 26.83 | Upgrade
|
| Operating Expenses | 277.25 | 293.26 | 391.07 | 358.26 | 332.38 | 511.73 | Upgrade
|
| Operating Income | 11.49 | 34.78 | 48.18 | 85.42 | 35.75 | 60.71 | Upgrade
|
| Interest Expense | -4.86 | -5.08 | -5.57 | -7.03 | -4.6 | -0.83 | Upgrade
|
| Interest & Investment Income | 3.5 | 3.65 | 6.26 | 6.47 | 8.22 | 9.22 | Upgrade
|
| Currency Exchange Gain (Loss) | 0 | 0 | 0.05 | 0.02 | 0.03 | 0.03 | Upgrade
|
| Other Non Operating Income (Expenses) | -3.09 | -0.82 | -0.32 | 0.01 | -0.58 | -3.34 | Upgrade
|
| EBT Excluding Unusual Items | 7.04 | 32.54 | 48.59 | 84.9 | 38.83 | 65.8 | Upgrade
|
| Impairment of Goodwill | - | - | -33.1 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -2.94 | -2.89 | -1.01 | -2.64 | -0.58 | -2 | Upgrade
|
| Asset Writedown | - | - | 16.2 | - | 0.86 | -13.59 | Upgrade
|
| Pretax Income | 4.1 | 29.64 | 30.67 | 82.26 | 39.11 | 50.21 | Upgrade
|
| Income Tax Expense | 9.55 | 15.88 | 16.15 | 18.43 | 4.8 | 11.47 | Upgrade
|
| Earnings From Continuing Operations | -5.45 | 13.77 | 14.53 | 63.83 | 34.31 | 38.74 | Upgrade
|
| Minority Interest in Earnings | 11.62 | 11.25 | 9.6 | -9.48 | 1.65 | -2.15 | Upgrade
|
| Net Income | 6.17 | 25.01 | 24.13 | 54.35 | 35.96 | 36.59 | Upgrade
|
| Net Income to Common | 6.17 | 25.01 | 24.13 | 54.35 | 35.96 | 36.59 | Upgrade
|
| Net Income Growth | -80.80% | 3.68% | -55.61% | 51.14% | -1.73% | -38.73% | Upgrade
|
| Shares Outstanding (Basic) | 1,678 | 1,678 | 1,678 | 1,678 | 1,678 | 1,678 | Upgrade
|
| Shares Outstanding (Diluted) | 1,678 | 1,678 | 1,678 | 1,678 | 1,678 | 1,678 | Upgrade
|
| EPS (Basic) | 0.00 | 0.01 | 0.01 | 0.03 | 0.02 | 0.02 | Upgrade
|
| EPS (Diluted) | 0.00 | 0.01 | 0.01 | 0.03 | 0.02 | 0.02 | Upgrade
|
| EPS Growth | -80.81% | 3.68% | -55.61% | 51.14% | -1.73% | -38.73% | Upgrade
|
| Free Cash Flow | 31.45 | 5.28 | 38.47 | 41.53 | -81.64 | 62.32 | Upgrade
|
| Free Cash Flow Per Share | 0.02 | 0.00 | 0.02 | 0.03 | -0.05 | 0.04 | Upgrade
|
| Dividend Per Share | 0.005 | 0.005 | - | - | - | - | Upgrade
|
| Gross Margin | 29.07% | 31.49% | 41.25% | 44.97% | 43.89% | 55.50% | Upgrade
|
| Operating Margin | 1.16% | 3.34% | 4.52% | 8.66% | 4.26% | 5.89% | Upgrade
|
| Profit Margin | 0.62% | 2.40% | 2.27% | 5.51% | 4.29% | 3.55% | Upgrade
|
| Free Cash Flow Margin | 3.17% | 0.51% | 3.61% | 4.21% | -9.73% | 6.04% | Upgrade
|
| EBITDA | 38.76 | 63.3 | 76.26 | 114.25 | 61.04 | 83.55 | Upgrade
|
| EBITDA Margin | 3.90% | 6.08% | 7.16% | 11.58% | 7.28% | 8.10% | Upgrade
|
| D&A For EBITDA | 27.28 | 28.52 | 28.08 | 28.82 | 25.29 | 22.84 | Upgrade
|
| EBIT | 11.49 | 34.78 | 48.18 | 85.42 | 35.75 | 60.71 | Upgrade
|
| EBIT Margin | 1.16% | 3.34% | 4.52% | 8.66% | 4.26% | 5.89% | Upgrade
|
| Effective Tax Rate | 232.94% | 53.57% | 52.64% | 22.41% | 12.28% | 22.84% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.